HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Novel Treatments for HIV Currently in Development

Paul Sax, MD, discusses treatments for HIV that are currently in development.

Segment Description: Paul Edward Sax, MD, clinical director, professor of medicine, Harvard Medical School; clinical director of the Division of Infectious Diseases at Brigham and Women’s Hospital, discusses treatments for HIV that are currently in development.

Contagion®: What are some novel treatments for HIV in phase 3? What makes them unique options?

Dr. Sax: “A very interesting new approach to managing patients with HIV, who already are successfully treated, is long-acting injectable treatments. Currently, in phase 3 is a combination injectable treatment of cabotegravir and rilpivirine to be given every 4 weeks as an injection. This is really sort of a transformative idea — it's a way of treating HIV without taking a pill every day.

The reason why it's so interesting is because even though we right now have wonderful treatments — just a single pill a day that can successfully treat HIV in essentially everybody – there are some people who really don't like taking pills. And, there are many people who say that taking a pill every day reminds them of their diagnosis and reminds them of the stigma associated with HIV and so they're very eagerly awaiting this new approach to treatment.”